Trial intelligence / Profile preview

Roxithromycin in stable non-cystic fibrosis bronchiectasis

ChiCTR-TRC-13003979Phase 4Completed

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of roxithromycin in bronchiectasis (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Thoracic CT scores and Markers of inflammation in sputum. Started May 2009; status: completed.

02

Drugs

roxithromycin
03

Conditions

bronchiectasis

Beyond the preview

Go deeper on ChiCTR-TRC-13003979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call